<?xml version="1.0" encoding="UTF-8"?>
<ref id="b3-1040138">
 <label>3.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lenz</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Dreyling</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Hoster</surname>
    <given-names>E</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)</article-title>. 
  <source>J Clin Oncol</source>. 
  <year>2005</year>;
  <volume>23</volume>(
  <issue>9</issue>):
  <fpage>1984</fpage>â€“
  <lpage>1992</lpage>.
  <pub-id pub-id-type="pmid">15668467</pub-id>
 </mixed-citation>
</ref>
